2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Multiple Myeloma
1
Lymphoma
1
Interventions
Cyclophosphamide
909
Carboplatin
786
Paclitaxel
741
pembrolizumab
741
Bevacizumab
715
Cisplatin
707
Gemcitabine
621
Docetaxel
583
Rituximab
558
Radiotherapy
546
Dexamethasone
510
Nivolumab
488
Doxorubicin
445
Fluorouracil
392
Capecitabine
382
Etoposide
357
Pemetrexed
336
Oxaliplatin
335
Cytarabine
334
Lenalidomide
327
Prednisone
327
Erlotinib Hydrochloride
323
fludarabine phosphate
315
Trastuzumab
305
Leucovorin
299
fludarabine
296
Vincristine
288
Bortezomib
284
Filgrastim
284
Cetuximab
275
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Exercise Therapy
×
Clear all
NCT06063603
2025-09-18
ASCENT
Mayo Clinic
Phase NA
Completed
51 enrolled
8 charts